NH

Niket Hiteshbhai Patel

Active Director Director DIN 02618793
DIN 02618793 First appointment Apr 2009 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 8 active board seats
Total affiliations 8 Since Apr 2009
Shareholding value •••• Premium profile

About Niket Hiteshbhai Patel

Data last updated:

Niket Hiteshbhai Patel is a Director at Sat Kaival Hospital Private Limited (since 2009), Director at Sat Kaival Medical Research Foundation (since 2013) and Director at Rayos Anand Cancer Institute & Research Centre Private Limited (since 2025), and holds 5 more current directorships. The companies operate in Healthcare and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹36.08 Cr; the largest is Sat Kaival Hospital Private Limited at ₹36.08 Cr (FY 2023).

DIN 02618793
Primary Designation Director
Industry Healthcare
First Appointment 20 Apr 2009
Oldest Company Age 17 yrs
Largest company Sat Kaival Hospital Private Limited · ₹36.08 Cr (FY 2023)
Combined revenue ₹36.08 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sat Kaival Hospital Private Limited U85110GJ2009PTC056671
Director20 Apr 20092009₹36.08 Cr (FY 2023)Active
Director25 Apr 20132013₹15,032 (FY 2025)Active
Director10 Sep 20252025Active
Designated Partner22 May 20212021Active
Designated Partner22 May 20212021Active
Designated Partner07 Apr 20212021Active
Savita Chhaya Foundation U85310GJ2016NPL094508
Director28 Nov 20162016Active
Akanksha Stemcell Private Limited U85110GJ2011PTC065846
Director10 Jun 20112011Active

Directorship timeline

Open interactive timeline →
Alemonia Life Sciences Limited Liability Partnership
La Diagnostic Laboratory Limited Liability Partnership
Sat Kaival Hospital Private Limited
Akanksha Stemcell Private Limited
Premium access

Shareholding and investment profile for Niket Hiteshbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Niket Hiteshbhai Patel

Niket Hiteshbhai Patel currently holds 8 directorships: Sat Kaival Hospital Private Limited (Director, since 20 Apr 2009, revenue ₹36.08 Cr (FY 2023)); Sat Kaival Medical Research Foundation (Director, since 25 Apr 2013, revenue ₹15,032 (FY 2025)); Rayos Anand Cancer Institute & Research Centre Private Limited (Director, since 10 Sep 2025); La Diagnostic Laboratory Limited Liability Partnership (Designated Partner, since 22 May 2021); Vraj Fertility Services Limited Liability Partnership (Designated Partner, since 22 May 2021); and 3 more.

Niket Hiteshbhai Patel was first appointed on 20 Apr 2009 as Director at Sat Kaival Hospital Private Limited. The most recent appointment on record is 10 Sep 2025 at Rayos Anand Cancer Institute & Research Centre Private Limited.

The 2 current companies of Niket Hiteshbhai Patel that report revenue have a combined latest revenue of ₹36.08 Cr: Sat Kaival Hospital Private Limited ₹36.08 Cr (FY 2023); Sat Kaival Medical Research Foundation ₹15,032 (FY 2025).

The current boards of Niket Hiteshbhai Patel's companies include Hiteshbhai Sumanbhai Patel (Sat Kaival Hospital Private Limited), Naynaben Patel (Sat Kaival Hospital Private Limited), Gayatri Kumpawat (Rayos Anand Cancer Institute & Research Centre Private Limited), Priyanka Srivastava (Rayos Anand Cancer Institute & Research Centre Private Limited), Kiranbhai Hiralal Marathe (La Diagnostic Laboratory Limited Liability Partnership), Geetaben Sanket Makadiya (Vraj Fertility Services Limited Liability Partnership), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available